aTyr Pharma, Inc.
Hedge Funds Holdings
Last updated:
aTyr Pharma, Inc.‘s stocks are currently a part of 17 hedge funds’ portfolios, which represents 92.72% of the total amount of its stocks outstanding. This makes up a total of 26.34M shares of aTyr Pharma, Inc.. Compared to the previous quarter, the number grew by 43.57% or 7.99M shares more. As for the holding position changes, 41.18% (7) of current hedge fund investors increased the number of shares held, 23.53% (4) of current holders sold a part of the shares held, and 29.41% (5) closed the holdings completely. 5 hedge funds are new holders of aTyr Pharma, Inc. stock in Q1 2023, it is 29.41% of total holders.
Hedge funds holding aTyr Pharma (Q2 2018 – Q1 2023)
| Q2 2018 | 31 |
|---|---|
| Q3 2018 | 27 |
| Q4 2018 | 23 |
| Q1 2019 | 23 |
| Q2 2019 | 20 |
| Q3 2019 | 16 |
| Q4 2019 | 14 |
| Q1 2020 | 22 |
| Q2 2020 | 22 |
| Q3 2020 | 21 |
| Q4 2020 | 20 |
| Q1 2021 | 20 |
| Q2 2021 | 25 |
| Q3 2021 | 40 |
| Q4 2021 | 45 |
| Q1 2022 | 38 |
| Q2 2022 | 34 |
| Q3 2022 | 32 |
| Q4 2022 | 35 |
| Q1 2023 | 17 |
Hedge funds changes in aTyr Pharma positions (Q2 2018 – Q1 2023)
| Q2 2018 | 8 | 3 | 4 | 10 | 6 |
|---|---|---|---|---|---|
| Q3 2018 | 5 | 5 | 6 | 9 | 2 |
| Q4 2018 | 2 | 4 | 3 | 6 | 8 |
| Q1 2019 | 2 | 4 | 3 | 2 | 12 |
| Q2 2019 | 9 | 5 | 4 | 12 | -10 |
| Q3 2019 | 10 | 2 | 4 | 14 | -14 |
| Q4 2019 | 5 | 2 | 3 | 2 | 2 |
| Q1 2020 | 10 | 7 | 0 | 1 | 4 |
| Q2 2020 | 4 | 7 | 4 | 5 | 2 |
| Q3 2020 | 3 | 8 | 2 | 4 | 4 |
| Q4 2020 | 5 | 6 | 4 | 6 | -1 |
| Q1 2021 | 4 | 9 | 4 | 4 | -1 |
| Q2 2021 | 7 | 9 | 4 | 2 | 3 |
| Q3 2021 | 18 | 15 | 5 | 3 | -1 |
| Q4 2021 | 16 | 10 | 11 | 10 | -2 |
| Q1 2022 | 7 | 12 | 10 | 14 | -5 |
| Q2 2022 | 5 | 7 | 11 | 9 | 2 |
| Q3 2022 | 2 | 15 | 5 | 4 | 6 |
| Q4 2022 | 8 | 12 | 8 | 5 | 2 |
| Q1 2023 | 5 | 7 | 4 | 5 | -4 |
Hedge funds changes in aTyr Pharma stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 96,000 | 12,000 |
| Q3 2021 | 8,094,000 | 3,075,000 |
| Q4 2021 | 656,000 | 703,000 |
| Q1 2022 | 445,000 | 1,202,000 |
| Q2 2022 | 64,000 | 436,000 |
| Q3 2022 | 72,000 | 403,000 |
| Q4 2022 | 17,607 | 91,380 |
| Q1 2023 | 1,267,000 | 0 |